BMC Pediatrics (Nov 2023)

Target product profiles for neonatal care devices: systematic development and outcomes with NEST360 and UNICEF

  • Rebecca P. Kirby,
  • Elizabeth M. Molyneux,
  • Queen Dube,
  • Cindy McWhorter,
  • Beverly D. Bradley,
  • Martha Gartley,
  • Z. Maria Oden,
  • Rebecca Richards-Kortum,
  • Jennifer Werdenberg-Hall,
  • Danica Kumara,
  • Sara Liaghati-Mobarhan,
  • Megan Heenan,
  • Meaghan Bond,
  • Chinyere Ezeaka,
  • Nahya Salim,
  • Grace Irimu,
  • Kara M. Palamountain,
  • the TPP Survey, Consensus Meeting Participants Collaborative Authorship Group

DOI
https://doi.org/10.1186/s12887-023-04342-1
Journal volume & issue
Vol. 23, no. S2
pp. 1 – 14

Abstract

Read online

Abstract Background Medical devices are critical to providing high-quality, hospital-based newborn care, yet many of these devices are unavailable in low- and middle-income countries (LMIC) and are not designed to be suitable for these settings. Target Product Profiles (TPPs) are often utilised at an early stage in the medical device development process to enable user-defined performance characteristics for a given setting. TPPs can also be applied to assess the profile and match of existing devices for a given context. Methods We developed initial TPPs for 15 newborn product categories for LMIC settings. A Delphi-like process was used to develop the TPPs. Respondents completed an online survey where they scored their level of agreement with each of the proposed performance characteristics for each of the 15 devices. Characteristics with 75% agreement. Areas of disagreement were voted on by 69 participants at an in-person consensus meeting, with consensus achieved for 648 (97%) performance characteristics. Only 20 (3%) performance characteristics did not achieve consensus, most (15/20) relating to quality management systems. UNICEF published the 15 TPPs in April 2020, accompanied by a report detailing the online survey results and consensus meeting discussion, which has been viewed 7,039 times (as of January 2023). Conclusions These 15 TPPs can inform developers and enable implementers to select neonatal care products for LMIC. Over 2,400 medical devices and diagnostics meeting these TPPs have been installed in 65 hospitals in Nigeria, Tanzania, Kenya, and Malawi through the NEST360 Alliance. Twenty-three medical devices identified and qualified by NEST360 meet nearly all performance characteristics across 11 of the 15 TPPs. Eight of the 23 qualified medical devices are available in the UNICEF Supply Catalogue. Some developers have adjusted their technologies to meet these TPPs. There is potential to adapt the TPP process beyond newborn care.

Keywords